FDA compounder NDC directory
Browse every current FDA compounder source row, including records that do not contain a usable NDC.
Compounder NDC directory#
Every current compounder source row is browsable, including records whose FDA source did not provide a usable product, package, or lookup NDC. Browse the unified current auxiliary catalog. · Browse the complete captured source and snapshot history.
| Establishment | FEI | Product NDC | Package NDC | Brand | Nonproprietary name | Active ingredients | Period | Normalization | Source date |
|---|---|---|---|---|---|---|---|---|---|
| Hybrid Pharma | 079665742 | 26436-5239 | 26436-5239-8 | Methylcobalamin | .5 mg/1 mL | 2020-1 | valid | 2026-11-14 | |
| Hybrid Pharma | 079665742 | 26436-5015 | 26436-5015-3 | Methylcobalamin | 1 mg/1 mL | 2020-1 | valid | 2026-11-14 | |
| Hybrid Pharma | 079665742 | 26436-5354 | 26436-5354-1 | Methylene Blue | 5 mg/1 mL | 2020-1 | valid | 2026-11-14 | |
| Hybrid Pharma | 079665742 | 26436-5001 | 26436-5001-5 | Ascorbic Acid | 500 mg/1 mL | 2020-1 | valid | 2026-11-14 | |
| Hybrid Pharma | 079665742 | 26436-5022 | 26436-5022-1 | Nandrolone Decanoate | 200 mg/1 mL | 2020-1 | valid | 2026-11-14 | |
| Hybrid Pharma | 079665742 | 26436-1115 | 26436-1115-1 | Oxandrolone | 25 mg | 2020-1 | valid | 2026-11-14 | |
| Hybrid Pharma | 079665742 | 26436-5375 | 26436-5375-1 | Oxandrolone | 50 mg | 2020-1 | valid | 2026-11-14 | |
| Hybrid Pharma | 079665742 | 26436-5137 | 26436-5137-5 | Papaverine Hydrochloride; Alprostadil; Phentolamine Mesylate | 30 mg/1 mL; 20 ug/1 mL; 2 mg/1 mL | 2020-1 | valid | 2026-11-14 | |
| Hybrid Pharma | 079665742 | 26436-5125 | 26436-5125-5 | Papaverine Hydrochloride; Alprostadil; Phentolamine Mesylate | 30 mg/1 mL; 20 ug/1 mL; 1 mg/1 mL | 2020-1 | valid | 2026-11-14 | |
| Hybrid Pharma | 079665742 | 26436-5044 | 26436-5044-3 | Procaine Hydrochloride | 20 mg/1 mL | 2020-1 | valid | 2026-11-14 | |
| Hybrid Pharma | 079665742 | 26436-5152 | 26436-5152-1 | Progesterone | 150 mg | 2020-1 | valid | 2026-11-14 | |
| Hybrid Pharma | 079665742 | 26436-5248 | 26436-5248-1 | Progesterone | 125 mg | 2020-1 | valid | 2026-11-14 | |
| Hybrid Pharma | 079665742 | 26436-5404 | 26436-5404-1 | Progesterone | 250 mg | 2020-1 | valid | 2026-11-14 | |
| Hybrid Pharma | 079665742 | 26436-5062 | 26436-5062-1 | Progesterone | 50 mg | 2020-1 | valid | 2026-11-14 | |
| Hybrid Pharma | 079665742 | 26436-5454 | 26436-5454-1 | Progesterone | 100 mg | 2020-1 | valid | 2026-11-14 | |
| Hybrid Pharma | 079665742 | 26436-5247 | 26436-5247-1 | Progesterone | 60 mg | 2020-1 | valid | 2026-11-14 | |
| Hybrid Pharma | 079665742 | 26436-5470 | 26436-5470-1 | Progesterone | 35 mg | 2020-1 | valid | 2026-11-14 | |
| Hybrid Pharma | 079665742 | 26436-5363 | 26436-5363-1 | Progesterone | 175 mg | 2020-1 | valid | 2026-11-14 | |
| Hybrid Pharma | 079665742 | 26436-5180 | 26436-5180-1 | Testosterone | 100 mg/1 mL | 2020-1 | valid | 2026-11-14 | |
| Hybrid Pharma | 079665742 | 26436-5244 | 26436-5244-5 | Testosterone | 150 mg/1 g | 2020-1 | valid | 2026-11-14 | |
| Hybrid Pharma | 079665742 | 26436-0163 | 26436-0163-5 | Testosterone | 100 mg/1 g | 2020-1 | valid | 2026-11-14 | |
| Hybrid Pharma | 079665742 | 26436-5146 | 26436-5146-1 | Testosterone Cypionate | 20 mg/1 mL | 2020-1 | valid | 2026-11-14 | |
| Hybrid Pharma | 079665742 | 26436-5074 | 26436-5074-1 | Testosterone Cypionate | 200 mg/1 mL | 2020-1 | valid | 2026-11-14 | |
| Hybrid Pharma | 079665742 | 26436-5345 | 26436-5345-1 | Testosterone Cypionate; Testosterone Propionate | 180 mg/1 mL; 20 mg/1 mL | 2020-1 | valid | 2026-11-14 | |
| Hybrid Pharma | 079665742 | 26436-5092 | 26436-5092-1 | Testosterone Enanthate | 200 mg/1 mL | 2020-1 | valid | 2026-11-14 | |
| Hybrid Pharma | 079665742 | 26436-5093 | 26436-5093-1 | Testosterone Propionate | 100 mg/1 mL | 2020-1 | valid | 2026-11-14 | |
| Hybrid Pharma | 079665742 | 26436-5030 | 26436-5030-3 | Cyanocobalamin | 1 mg/1 mL | 2020-1 | valid | 2026-11-14 | |
| Hybrid Pharma | 079665742 | 26436-5009 | 26436-5009-3 | Cyanocobalamin | 1000 ug/1 mL | 2020-1 | valid | 2026-11-14 | |
| Hybrid Pharma | 079665742 | 26436-5130 | 26436-5130-1 | "phenylephrine Hydrochloride, (+/-)-" | 1 mg/1 mL | 2020-1 | valid | 2026-11-14 | |
| Hybrid Pharma | 079665742 | 26436-5150 | 26436-5150-1 | Doxycycline Hyclate | .25 mg/1 mL | 2020-1 | valid | 2026-11-14 | |
| Hybrid Pharma | 079665742 | 26436-5342 | 26436-5342-1 | Estriol | 2 mg | 2020-1 | valid | 2026-11-14 | |
| Hybrid Pharma | 079665742 | 26436-5343 | 26436-5343-1 | Estriol | 2 mg | 2020-1 | valid | 2026-11-14 | |
| Hybrid Pharma | 079665742 | 26436-5228 | 26436-5228-3 | Estriol; Estradiol | 2 mg/1 g; .5 mg/1 g | 2020-1 | valid | 2026-11-14 | |
| Hybrid Pharma | 079665742 | 26436-5246 | 26436-5246-3 | Estriol; Testosterone; Estradiol | 1.6 mg/1 g; 1 mg/1 g; .4 mg/1 g | 2020-1 | valid | 2026-11-14 | |
| Hybrid Pharma | 079665742 | 26436-5037 | 26436-5037-5 | Alprostadil; Papaverine Hydrobromide; Phentolamine Mesylate | 10 ug/1 mL; 30 mg/1 mL; 1 mg/1 mL | 2020-1 | valid | 2026-11-14 | |
| Hybrid Pharma | 079665742 | 26436-9021 | 26436-9021-4 | Hydromorphone Hydrochloride; Bupivacaine Hydrochloride Related Compound A | 20 mg/1 mL; 2 mg/1 mL | 2020-1 | valid | 2026-11-14 | |
| Hybrid Pharma | 079665742 | 26436-9020 | 26436-9020-2 | Hydromorphone Hydrochloride; Bupivacaine Hydrochloride Related Compound A | 20 mg/1 mL; 10 mg/1 mL | 2020-1 | valid | 2026-11-14 | |
| Hybrid Pharma | 079665742 | 26436-5105 | 26436-5105-5 | Magnesium Chloride | 200 mg/1 mL | 2020-1 | valid | 2026-11-14 | |
| IAP Production | 105900416 | 77510-001 | 77510-001-01 | Isopropyl Alcohol | 30 mL/30 mL | 2020-1 | valid | 2026-11-14 | |
| JCB Laboratories LLC | 177167470 | 71266-1065 | 71266-1065-1 | Methylprednisolone Acetate | 80 mg/1 mL | 2020-1 | valid | 2026-11-14 | |
| JCB Laboratories LLC | 177167470 | 71266-8515 | 71266-8515-1 | Mitomycin | .4 mg/1 mL | 2020-1 | valid | 2026-11-14 | |
| JCB Laboratories LLC | 177167470 | 71266-8475 | 71266-8475-1 | Mitomycin | .2 mg/1 mL | 2020-1 | valid | 2026-11-14 | |
| JCB Laboratories LLC | 177167470 | 71266-8510 | 71266-8510-1 | Mitomycin | .3 mg/1 mL | 2020-1 | valid | 2026-11-14 | |
| JCB Laboratories LLC | 177167470 | 71266-6412 | 71266-6412-2 | Mitomycin | .5 mg/1 mL | 2020-1 | valid | 2026-11-14 | |
| JCB Laboratories LLC | 177167470 | 71266-8603 | 71266-8603-1 | Moxifloxacin Hydrochloride | 1 mg/1 mL | 2020-1 | valid | 2026-11-14 | |
| JCB Laboratories LLC | 177167470 | 71266-8602 | 71266-8602-1 | Moxifloxacin Hydrochloride | 5 mg/1 mL | 2020-1 | valid | 2026-11-14 | |
| JCB Laboratories LLC | 177167470 | 71266-6509 | 71266-6509-1 | Phenol | 60 mg/1 mL | 2020-1 | valid | 2026-11-14 | |
| JCB Laboratories LLC | 177167470 | 71266-8526 | 71266-8526-1 | Phenylephrine Hydrochloride | 15 mg/1 mL | 2020-1 | valid | 2026-11-14 | |
| JCB Laboratories LLC | 177167470 | 71266-6350 | 71266-6350-1 | Phenylephrine Hydrochloride; Lidocaine Hydrochloride | 15 mg/1 mL; 10 mg/1 mL | 2020-1 | valid | 2026-11-14 | |
| JCB Laboratories LLC | 177167470 | 71266-8210 | 71266-8210-1 | Phenylephrine Hydrochloride; Tropicamide; Cyclopentolate Hydrochloride | 25 mg/1 mL; 10 mg/1 mL; 10 mg/1 mL | 2020-1 | valid | 2026-11-14 |